Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

European Innovation Council · Running

PRISM Predictive Research for Inflammatory Systems Medicine

Coordinator
Scienta Lab, France
Runs
1 December 2025 to 30 November 2027
Status
Running
EU funding
€2.5m
Total cost
—
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
101247838

What the project is doing

In the project's own words, from its summary on CORDIS.

The immune system and its disorders are particularly complex to model, posing significant challenges for drug development. Due tothe limited representativeness of preclinical models, nearly half of clinical trial failures in immunology and inflammation stem frominsufficient efficacy. The rise of artificial intelligence capabilities offers a transformative opportunity to address this issue. With the support of the EICAccelerator project, France-based start-up Scienta Lab aims to develop a proprietary multimodal foundation model speciallydesigned for immunology and inflammation.

This advanced AI technology will enhance traditional preclinical approaches byvalidating the efficacy of new assets at the preclinical stage. By improving clinical trial success rates of innovative best-in-class assets,this innovation paves the way for precision medicine in immunology and inflammation.

Topics

Who is involved

OrganisationCityCountryRole
Scienta LabGif-Sur-YvetteFranceCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI